Evidence map›Paper›PMID 36967213›Full record

ArticleIndian journal of medical microbiology

Effectiveness of sample pooling strategies for diagnosis of SARS-CoV-2: Specimen pooling vs. RNA elutes pooling.

Vijaylakshmi Jain, Nikita Sherwani, Niza Monga, Aparna Sahu

Open access · goldAbstract read
In one paragraph

Article in Indian journal of medical microbiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Vijaylakshmi JainViral Diagnostic Laboratory, Department of Microbiology, Pt J.N.M Medical College, Raipur (C.G.), India. Electronic address: vjgolchha.jain@gmail.com.
Nikita SherwaniViral Diagnostic Laboratory, Department of Microbiology, Pt J.N.M Medical College, Raipur (C.G.), India. Electronic address: drnikita.sherwani@gmail.com.
Niza MongaDepartment of Microbiology, Mahasamund Medical College, Mahasamund (C.G.), India. Electronic address: nizamonga123@gmail.com.
Aparna SahuViral Diagnostic Laboratory, Department of Microbiology, Pt J.N.M Medical College, Raipur (C.G.), India. Electronic address: appysahu16@gmail.com.
Pt. Jawahar Lal Nehru Memorial Medical College · INMahasarakham University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe pandemic of SARS-CoV-2 or COVID-19 has hugely created an economic imbalance worldwide. With the exponential increase in the number of cases and to keep in check on the community transmission, there is high demand and acute shortage of diagnostic kits. The pooled-sample strategy turns out to be the promising strategy intended to determine the optimal testing for specimens with limited resources and without losing the test sensitivity and specificity. The study was performed with standard molecular biology graded lab equipment, FDA-approved COVID-19 RNA extraction, and SARS-CoV-2 tests kits. MATERIALS AND

methodsThe study aims to comparatively analyze the pooling strategy of the naso-oropharyngeal specimen sample and RNA extracted from the same patient samples in the pool of 3,5, and 8 with no significant loss in test usability. Another primary focus of the study was detection of low or borderline SARS-CoV-2 positives in the pooling strategy. A total of 300 samples (240 positives and 60 negatives) were tested for 3, 5, and 8 pools of specimen samples and RNA elutes.

resultsThe comparative analysis determined the sensitivity for three and five pool strategy to be above 98% and eight pool strategy to be 100%.

conclusionThe RNA elutes pooling strategy concordance rate is better than that of specimen pooling with 100% specificity. Thus, in the substantial crisis of resources with the global pandemic, pooling approaches for SARS-CoV-2 can be practical in a low prevalence rate of 5%.

Indexed as

COVID-19SARS-CoV-2COVID-19 TestingHumansRNA, ViralSensitivity and SpecificitySpecimen HandlingRNA, ViralEmerging infectious diseaseMolecular biologyRNA poolingRT-PCRSARS-CoV infection

Identifiers

PMID36967213
PMCPMC9870240
OpenAlexW4317771618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.